headshot photo of Dr. Sherry Wang

Dr. Sherry Wang

Assistant Professor
School of Pharmacy
Office Location: Rinker Health Science Campus 94-206
Phone: 714-516-5487
China Pharmaceutical University, Bachelor of Science
University of Hong Kong, Master of Philosophy
The Chinese University of Hong Kong, Ph.D.


Dr. Yun “Sherry” WANG is a tenure-track Assistant Professor in the Department of Pharmaceutical Economics and Policy (PEP) at Chapman University School of Pharmacy (CUSP). She currently leads the Patient Safety Lab. Before joining Chapman, she worked in the fields of global health, epidemiology, social science, clinical pharmacy, health economics, and health service research in Asia, Australia, and America. She is also an Alumni Affiliates at the Center for the Study of Race, Ethnicity & Equity, Washington University in St Louis.

Her research interests lie in pharmacoepidemiology and health service research for substance users and chronic disease patients. Her lab investigates California’s Prescription Drug Monitoring Programs (PDMPs) from 10-year real-world data of the Controlled Substance Utilization Review and Evaluation System (CURES) database, medication-assisted treatments, and opioid prescribing before and after Covid-19 in California, real-world evidence for personalized medicine for cardiovascular diseases, and the health disparity in Covid-19 exposure risks and treatment outcomes. These projects bring together more than ten faculty and students and are led by herself and her collaborators in and out of Chapman.

Sherry has published peer-reviewed articles in JAMA, Lancet, Clinical Infectious Disease, International Journal of Cardiology, The pharmacogenomics journal, Drug and Alcohol Dependence, Pain reports, Neuroepidemiology, etc. She served as Editor for the Special Issue "Opioid Epidemic during the COVID-19 Pandemic" of the journal Healthcare. Her research was highlighted in ISPOR News Across Asia and the COVID newsletter by the Washington State Department of Health.

Her recent Ph. D. student received the 2022 James L. Doti Outstanding Graduate Student Award, the highest honor for graduate students at Chapman University. She is open to working with Ph.D. students, postdocs, and visiting scholars.

Selected Publications

Peer-reviewed journal papers

Yun Wang (corresponding), Dan Wu, Alexandre Chan, Chih-Hung Chang, Vivian WY Lee, and Michael B. Nichol. "Temporal trend of opioid and nonopioid pain medications: results from a national in-home survey, 2001 to 2018." Pain reports 7, no. 3 (2022).

Yun Wang, Alex Chan, Michael Nichol, Gilbert Samia, Joan Wu, Marc Fleming. Real-World Dispensing of Buprenorphine and Methadone from MAR 2019 to MAR 2021 in California. Value in Health. 2022 Jul 1;25(7):S587.

Yun Wang, Ying Liu, Mary Waldron, Alexandra N. Houston-Ludlam, Vivia V. McCutcheon, Michael T. Lynskey, Pamela AF Madden, Kathleen K. Bucholz, Andrew C. Heath, and Min Lian. “Temporal Trends in Smoking and Nicotine Dependence in Relation to Co-Occurring Substance Use in the United States, 2005-2016.” Drug and Alcohol Dependence (2021): 108903.

Yun Wang, Ying Liu, James Struthers, Min Lian, Spatiotemporal Characteristics of the COVID-19 Epidemic in the United States, Clinical Infectious Diseases, Volume 72, Issue 4, 15 February 2021, Pages 643–651, https://doi.org/10.1093/cid/ciaa934

Yun Wang, Srikanth Velandai, Snowdon David A., Ellmers Sonya, Beare Richard, Moran Chris, Richardson Dean, Lotz Peter, and Andrew Nadine E” Quantifying the economic benefit of the personal alarm and emergency response system in Australia: a cost analysis of the reduction in ambulance attendances.” Australian Health Review (2020). 45, 51-58.

Yun Wang, Bryan P. Yan, Brian Tomlinson, and Vivian WY Lee. “Is lipid goal one-size-fits-all: A review of evidence for recommended low-density lipoprotein treatment targets in Asian patients.” European journal of preventive cardiology 26, no. 14 (2019): 1496-1506.

Yun Wang, Michael B. Nichol, Bryan PY Yan, Joanne Wu, Brian Tomlinson, and Vivian WY Lee. “Descriptive analysis of real-world medication use pattern of statins and antiplatelet agents among patients with acute coronary syndrome in Hong Kong and the USA.” BMJ open 9, no. 7 (2019): e024937.

Yun Wang, Bryan Ping Yen Yan, Brian Tomlinson, Michael Bruce Nichol, and Vivian Wing Yan Lee. “Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention.” Journal of atherosclerosis and thrombosis 25, no. 12 (2018): 1255-1273.

Yun Wang, B. P. Yan, D. Liew, and V. W. Y. Lee. “Cost-effectiveness of cytochrome P450 2C19* 2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome.” The pharmacogenomics journal 18, no. 1 (2018): 113-120.

Yun Wang, Bryan P. Yan, Michael B. Nichol, Brian Tomlinson, and Vivian WY Lee. “Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients.” International journal of cardiology 249 (2017): 18-24.

Hesketh, Therese, Xudong Zhou, and Yun Wang. “The end of the one-child policy: lasting implications for China.” Jama 314, no. 24 (2015): 2619-2620.

Yun Wang, Sai Yin Ho, Man Ping Wang, Wing Sze Lo, Hak Kan Lai, and Tai Hing Lam. “Hong Kong Chinese adolescents’ self-reported smoking and perceptions of parenting styles.” International journal of behavioral medicine 22, no. 2 (2015): 268-275.

Book Chapters

Vivian WY Lee, Yun Wang, Joyce TS Li, Amy SM Lam. “Evidence and Trends of Clinical Pharmacy Services to Prevent and Manage Heart Disease and Stroke.” Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy (2023), Springer International Publishing, underprint

Chen, Ying-Yeh, Kevin Chien-Chang Wu, Yun Wang and Paul SF Yip. “Suicide prevention through restricting access to suicide means and hotspots.” (2016). The International Handbook of Suicide.